Your browser doesn't support javascript.
loading
Behavioral activation therapy for depression is associated with a reduction in the concentration of circulating quinolinic acid.
Savitz, Jonathan; Ford, Bart N; Yeh, Hung-Wen; Akeman, Elisabeth; Cosgrove, Kelly; Clausen, Ashley N; Martell, Christopher; Kirlic, Namik; Santiago, Jessica; Teague, T Kent; Irwin, Michael R; Paulus, Martin P; Aupperle, Robin L.
  • Savitz J; Laureate Institute for Brain Research, Tulsa, OK, USA.
  • Ford BN; Oxley College of Health Sciences, The University of Tulsa, Tulsa, OK, USA.
  • Yeh HW; Laureate Institute for Brain Research, Tulsa, OK, USA.
  • Akeman E; Childrens' Mercy Hospital, Kansas City, MO, USA.
  • Cosgrove K; Laureate Institute for Brain Research, Tulsa, OK, USA.
  • Clausen AN; Laureate Institute for Brain Research, Tulsa, OK, USA.
  • Martell C; Department of Psychology, The University of Tulsa, Tulsa, OK, USA.
  • Kirlic N; Kansas City VA Healthcare System, Kansas City, MO, USA.
  • Santiago J; Department of Psychiatry and Behavioral Sciences, University of Kansas Medical Center, Kansas City, MO, USA.
  • Teague TK; Department of Psychological and Brain Sciences, University of Massachusetts Amherst, Amherst, MO, USA.
  • Irwin MR; Laureate Institute for Brain Research, Tulsa, OK, USA.
  • Paulus MP; Laureate Institute for Brain Research, Tulsa, OK, USA.
  • Aupperle RL; Department of Surgery, University of Oklahoma School of Community Medicine, Tulsa, OK, USA.
Psychol Med ; 52(13): 2500-2509, 2022 10.
Article en En | MEDLINE | ID: mdl-33234171

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastorno Depresivo Mayor / Quinurenina Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastorno Depresivo Mayor / Quinurenina Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article